Back
Verrica Pharmaceuticals Vs. Hims & Hers Health Industry Stock Comparison
Sell
22
VRCA
Verrica Pharmaceuticals
Last Price:
$0.42
Seasonality Move:
-7.87%
Sell
38
HIMS
Hims & Hers Health
Last Price:
$31.29
Seasonality Move:
-0.33%
Sell
22
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy, Sell or Hold?
-
The current Verrica Pharmaceuticals [VRCA] share price is $0.44. The Score for VRCA is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
VRCA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Hims & Hers Health (HIMS)
is a Sell
Is Hims & Hers Health a Buy, Sell or Hold?
-
The current Hims & Hers Health [HIMS] share price is $29.55. The Score for HIMS is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
-
HIMS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
VRCA Stock Price Chart
What is Verrica Pharmaceuticals's stock price today?
-
The Verrica Pharmaceuticals share price today is $0.44Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing buying pressure, which is a positive indicator for future bullish movement.
HIMS Stock Price Chart
What is Hims & Hers Health's stock price today?
-
The Hims & Hers Health share price today is $29.55Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HIMS is experiencing buying pressure, which is a positive indicator for future bullish movement.
VRCA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.06 | Sell |
Relative Strength Index (14 RSI): | 31.21 | Sell |
Chaikin Money Flow: | 430723 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.51 - 0.67) | Sell |
Bollinger Bands (100): | (0.55 - 0.97) | Sell |
HIMS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.55 | Sell |
Relative Strength Index (14 RSI): | 39.28 | Sell |
Chaikin Money Flow: | 11512981 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (31.51 - 41.23) | Sell |
Bollinger Bands (100): | (23.32 - 42.22) | Sell |
VRCA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.49 | Sell |
20-day SMA: | 0.57 | Sell |
50-day SMA: | 0.64 | Sell |
200-day SMA: | 2.56 | Sell |
8-day EMA: | 0.48 | Sell |
20-day EMA: | 0.55 | Sell |
50-day EMA: | 0.66 | Sell |
200-day EMA: | 2.12 | Sell |
HIMS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.26 | Sell |
20-day SMA: | 34.59 | Sell |
50-day SMA: | 38.67 | Sell |
200-day SMA: | 25.95 | Buy |
8-day EMA: | 32.35 | Sell |
20-day EMA: | 35.13 | Sell |
50-day EMA: | 36.18 | Sell |
200-day EMA: | 27.62 | Buy |
Verrica Pharmaceuticals Earnings Growth & VRCA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.26 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.94 per share, and an increase next year of $0.16 per share.
Hims & Hers Health Earnings Growth & HIMS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $0.20 per share.
Verrica Pharmaceuticals Technical Analysis
Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Hims & Hers Health Technical Analysis
Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
18 | 19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |